Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy

Circulation

Volumn 118, Issue 20, 2008, Pages 2022-2028

  Gold, Michael R ^a,g   Ip, John H ^b   Costantini, Otto ^c   Poole, Jeanne E ^d   McNulty, Steven ^e   Mark, Daniel B ^e   Lee, Kerry L ^e   Bardy, Gust H ^d,f  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e DUKE UNIVERSITY   (United States)

^f Seattle Institute for Cardiac Research   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Defibrillation; Electrocardiography; Heart failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SUDDEN DEATH; SYSTOLIC DYSFUNCTION; T WAVE;

AGED; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE SUSCEPTIBILITY; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SINGLE-BLIND METHOD; SYSTOLE; VENTRICULAR DYSFUNCTION;

EID: 57149125829     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.748962     Document Type: Article

References (33)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
3. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
4. Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon R, Mitchell L, Green M, Klein G, O'Brien B. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352: 225-237.
7. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350: 2140-2150.
8. Radish A, Dyer A, Daubert J, Quigg R, Estes NA, Anderson K, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders W, Schaechter A, Levine J; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350:2151-2158.
9. Buxton AE. Sudden death after myocardial infarction: who needs prophylaxis, and when? N Engl J Med. 2005;352:2638-2640.
10. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; for the SCD-HeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114:135-142.
11. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353:1471-1480.
12. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330:235-241.
13. Gold MR, Bloomfield DM, Anderson KP, El-Sherif NE, Wilber DJ, Groh WJ, Estes NA III, Kaufman ES, Greenberg ML, Rosenbaum DS. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000;36:2247-2253.
14. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol. 2005;46:75-82.
15. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol. 2003;41: 2220-2224.
16. Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol. 1998;9:1258-1268.
17. Ikeda T, Saito H, Tanno K, Shimizu H, Watanabe J, Ohnishi Y, Kasamaki Y, Ozawa Y. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol. 2002;89:79-82.
18. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;47:456-463.
19. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol. 2002;13: 770-775.
20. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004;110: 1885-1889.
21. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Chan PS. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2006;47:1820-1827.
22. Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol. 2002;13: 845-850.
23. Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. Effect of heart rate on T wave alternans. J Cardiovasc Electrophysiol. 1997;8:987-993.
24. Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classifi-cation of microvolt T wave alternans tests J Cardiovasc Electrophysiol. 2002;13:502-512.
25. Rashba EJ, Cooklin M, MacMurdy K, Kavesh N, Kirk M, Sarang S, Peters RW, Shorofsky SR, Gold MR. Effects of selective autonomic blockade on T wave alternans in humans. Circulation. 2002;105: 837-842.
26. Kaufman ES, Bloomfield DM, Steinman RC, Naverow PB, Costantini O, Cohen RJ, Bigger JT. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;48: 1399-1404.
27. Groh WJ, Shinn TS, Engelstein EE, Zipes DP. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999;10:1335-1339.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
29. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B. 1972;34:187-220.
30. Morin DP, Zacks ES, Mauer AC, Ageno S, Janik M, Markowitz SM, Mittal S, Iwai S, Shah K, Lerman BB, Stein KM. Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in ischemic cardiomyopathy. Heart Rhythm. 2007;4:904-912.
31. Cantillon DJ, Stein KM, Markowitz, SM, Mittal S, Shah BK, Morin DP. Zacks ES, Janik M, Ageno S, Mauer AC, Lerman BB, Iwai S. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol. 2007;50:166-173.
32. Kavesh NG, Shorofsky SR, Sarang SE, Gold MR. The effect of procainamide on T-wave alternans. J Cardiovasc Electrophysiol. 1999;10: 649-654.
33. Klingenheben T. Microvolt T-wave altermans for arrhythmia risk stratification in left ventricular dysfunction: which patients benefit? J Am Coll Cardiol. 2007;50:174-175.